Mitsu Chem Plast Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 16, 2025, 7:47 pm

Competitors of Mitsu Chem Plast Ltd

All Competitor Stocks of Mitsu Chem Plast Ltd

Quarterly Result

Last Updated: August 19, 2025, 12:50 pm

Below is a detailed analysis of the quarterly data for Mitsu Chem Plast Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 85.28 Cr.. The value appears to be declining and may need further review. It has decreased from 90.47 Cr. (Mar 2025) to 85.28 Cr., marking a decrease of 5.19 Cr..
• For Expenses, as of Jun 2025, the value is 80.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.25 Cr. (Mar 2025) to 80.27 Cr., marking a decrease of 1.98 Cr..
• For Operating Profit, as of Jun 2025, the value is 5.01 Cr.. The value appears to be declining and may need further review. It has decreased from 8.22 Cr. (Mar 2025) to 5.01 Cr., marking a decrease of 3.21 Cr..
• For OPM %, as of Jun 2025, the value is 5.87%. The value appears to be declining and may need further review. It has decreased from 9.09% (Mar 2025) to 5.87%, marking a decrease of 3.22%.
• For Other Income, as of Jun 2025, the value is 0.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.04 Cr. (Mar 2025) to 0.13 Cr., marking an increase of 0.09 Cr..
• For Interest, as of Jun 2025, the value is 1.51 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.75 Cr. (Mar 2025) to 1.51 Cr., marking a decrease of 0.24 Cr..
• For Depreciation, as of Jun 2025, the value is 1.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.76 Cr. (Mar 2025) to 1.84 Cr., marking an increase of 0.08 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.79 Cr.. The value appears to be declining and may need further review. It has decreased from 4.75 Cr. (Mar 2025) to 1.79 Cr., marking a decrease of 2.96 Cr..
• For Tax %, as of Jun 2025, the value is 26.26%. The value appears to be increasing, which may not be favorable. It has increased from 25.68% (Mar 2025) to 26.26%, marking an increase of 0.58%.
• For Net Profit, as of Jun 2025, the value is 1.31 Cr.. The value appears to be declining and may need further review. It has decreased from 3.54 Cr. (Mar 2025) to 1.31 Cr., marking a decrease of 2.23 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.96. The value appears to be declining and may need further review. It has decreased from 2.61 (Mar 2025) to 0.96, marking a decrease of 1.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:01 am

Growth

Last Updated: September 5, 2025, 3:55 pm

Balance Sheet

Last Updated: July 25, 2025, 12:59 pm

Below is a detailed analysis of the balance sheet data for Mitsu Chem Plast Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 83.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2024) to 83.00 Cr., marking an increase of 16.00 Cr..
• For Borrowings, as of Mar 2025, the value is 69.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 80.00 Cr. (Mar 2024) to 69.00 Cr., marking a decrease of 11.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing). It has decreased from 35.00 Cr. (Mar 2024) to 30.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 195.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 194.00 Cr. (Mar 2024) to 195.00 Cr., marking an increase of 1.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 91.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2024) to 91.00 Cr., marking an increase of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 104.00 Cr.. The value appears to be declining and may need further review. It has decreased from 106.00 Cr. (Mar 2024) to 104.00 Cr., marking a decrease of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 195.00 Cr.. The value appears strong and on an upward trend. It has increased from 194.00 Cr. (Mar 2024) to 195.00 Cr., marking an increase of 1.00 Cr..

Notably, the Reserves (83.00 Cr.) exceed the Borrowings (69.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Mitsu Chem Plast Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.39. This value is within the healthy range. It has decreased from 7.12 (Mar 24) to 5.39, marking a decrease of 1.73.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.39. This value is within the healthy range. It has decreased from 7.10 (Mar 24) to 5.39, marking a decrease of 1.71.
• For Cash EPS (Rs.), as of Mar 25, the value is 10.41. This value is within the healthy range. It has decreased from 11.60 (Mar 24) to 10.41, marking a decrease of 1.19.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.42. It has increased from 61.88 (Mar 24) to 71.42, marking an increase of 9.54.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.42. It has increased from 61.88 (Mar 24) to 71.42, marking an increase of 9.54.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.20.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 244.72. It has increased from 242.65 (Mar 24) to 244.72, marking an increase of 2.07.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.59. This value is within the healthy range. It has decreased from 20.82 (Mar 24) to 17.59, marking a decrease of 3.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has decreased from 16.13 (Mar 24) to 12.52, marking a decrease of 3.61.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.37. This value is within the healthy range. It has decreased from 9.27 (Mar 24) to 7.37, marking a decrease of 1.90.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.34. This value is within the healthy range. It has decreased from 6.91 (Mar 24) to 5.34, marking a decrease of 1.57.
• For PBDIT Margin (%), as of Mar 25, the value is 7.18. This value is below the healthy minimum of 10. It has decreased from 8.58 (Mar 24) to 7.18, marking a decrease of 1.40.
• For PBIT Margin (%), as of Mar 25, the value is 5.11. This value is below the healthy minimum of 10. It has decreased from 6.64 (Mar 24) to 5.11, marking a decrease of 1.53.
• For PBT Margin (%), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 10. It has decreased from 3.82 (Mar 24) to 3.01, marking a decrease of 0.81.
• For Net Profit Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 5. It has decreased from 2.84 (Mar 24) to 2.18, marking a decrease of 0.66.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.47. This value is below the healthy minimum of 15. It has decreased from 11.16 (Mar 24) to 7.47, marking a decrease of 3.69.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has decreased from 18.81 (Mar 24) to 14.74, marking a decrease of 4.07.
• For Return On Assets (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has decreased from 4.56 (Mar 24) to 3.70, marking a decrease of 0.86.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 0.2. It has decreased from 0.31 (Mar 24) to 0.11, marking a decrease of 0.20.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.71. This value is within the healthy range. It has decreased from 1.01 (Mar 24) to 0.71, marking a decrease of 0.30.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.70. It has increased from 1.68 (Mar 24) to 1.70, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 1.5. It has increased from 1.20 (Mar 24) to 1.24, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 24) to 0.86, marking an increase of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.29. This value exceeds the healthy maximum of 8. It has increased from 5.52 (Mar 24) to 9.29, marking an increase of 3.77.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.74. This value is below the healthy minimum of 20. It has increased from 2.72 (Mar 24) to 3.74, marking an increase of 1.02.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 20. It has increased from 1.62 (Mar 24) to 1.92, marking an increase of 0.30.
• For Earning Retention Ratio (%), as of Mar 25, the value is 96.26. This value exceeds the healthy maximum of 70. It has decreased from 97.28 (Mar 24) to 96.26, marking a decrease of 1.02.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.08. This value exceeds the healthy maximum of 70. It has decreased from 98.38 (Mar 24) to 98.08, marking a decrease of 0.30.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.42. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 3.42, marking an increase of 0.38.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.04. This value is below the healthy minimum of 3. It has increased from 2.01 (Mar 24) to 2.04, marking an increase of 0.03.
• For Enterprise Value (Cr.), as of Mar 25, the value is 183.51. It has decreased from 267.24 (Mar 24) to 183.51, marking a decrease of 83.73.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.55, marking a decrease of 0.30.
• For EV / EBITDA (X), as of Mar 25, the value is 7.68. This value is within the healthy range. It has decreased from 10.01 (Mar 24) to 7.68, marking a decrease of 2.33.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.60 (Mar 24) to 0.34, marking a decrease of 0.26.
• For Retention Ratios (%), as of Mar 25, the value is 96.25. This value exceeds the healthy maximum of 70. It has decreased from 97.27 (Mar 24) to 96.25, marking a decrease of 1.02.
• For Price / BV (X), as of Mar 25, the value is 1.18. This value is within the healthy range. It has decreased from 2.36 (Mar 24) to 1.18, marking a decrease of 1.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.60 (Mar 24) to 0.34, marking a decrease of 0.26.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness